Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 2, multicenter, Open-Label, Long-Term Safety Study of LP352 in Subjects with Developmental and Epileptic Encephalopathy who Completed Study LP352-201 and are Candidates for Continuous Treatmen
Sponsored by Longboard Pharmaceuticals, Inc.
Active
$19.8K Funding
3 People
External
Related Topics
epileptic encephalopathy,
long-term safety,
developmental disorders,
continuous treatment
People
Gustavo Cornejo
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator III
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
David Labiner
Principal Investigator (PI)
Neurology
﹒Department Head
